Video Experimental Relacionado
Updated: Jul 18, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Evaluación clínica de la enfermedad inducida por drogas
1Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas 75390-8859, USA. rebecca.gruchalla@email.swmed.edu
Lancet (London, England)
|November 18, 2000
Resumen
Esta revisión ayuda a los médicos a administrar a los pacientes que informan alergias a los medicamentos, al distinguir las reacciones alérgicas verdaderas de las enfermedades no inmunológicas inducidas por medicamentos. Guía la reintroducción segura de medicamentos cuando sea posible.
Área de la Ciencia:
- Inmunología Clínica Inmunología Clínica.
- Farmacología Farmacología.
- Medicina interna es la medicina interna de las enfermedades.
Sus antecedentes:
- Los pacientes con frecuencia informan de "alergias a los medicamentos", lo que complica las decisiones de prescripción y la atención al paciente.
- Diferenciar verdaderas reacciones alérgicas a medicamentos de otros eventos adversos de medicamentos es clínicamente desafiante.
Objetivo del estudio:
- Proporcionar a los médicos un marco para el manejo de pacientes con sospechas de enfermedades inducidas por medicamentos.
- Diferenciar entre las reacciones alérgicas mediadas inmunológicamente y los eventos adversos no alérgicos.
Principales métodos:
- Revisión de la literatura médica sobre enfermedades inducidas por medicamentos y reacciones alérgicas.
- Discusión de las herramientas de evaluación clínica, incluyendo la historia clínica, los hallazgos físicos y las pruebas de laboratorio.
- Orientación sobre la re-administración segura de drogas sospechosas.
Principales resultados:
- Proporciona criterios para distinguir verdaderas reacciones alérgicas a medicamentos de otras afecciones inducidas por medicamentos.
- Destaca la importancia de una historia clínica exhaustiva del paciente y la evaluación diagnóstica.
- Ofrece estrategias para el manejo de pacientes con antecedentes de reacciones adversas a los medicamentos.
Conclusiones:
- El diagnóstico preciso de la hipersensibilidad a los medicamentos es crucial para una prescripción segura.
- Se necesita más investigación sobre los mecanismos de las reacciones inducidas por drogas para mejorar la gestión.
- Los médicos pueden mejorar la atención al paciente mediante la evaluación sistemática de las alergias a los medicamentos reportadas.
Videos de Conceptos Relacionados
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).